BioCentury
ARTICLE | Financial News

Esperion completes IPO

July 1, 2013 7:00 AM UTC

Esperion Therapeutics Inc. (NASDAQ:ESPR), Plymouth, Mich. Business: Endocrine/Metabolic, Cardiovascular Date completed: 6/26/13 Type: IPO Raised: $70 million Shares: 5 million Price: $14 Shares after ...